Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GPCR antagonists(G-protein coupled receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H19N3O5S2 |
InChIKeyXLSQVBRMGFLMGL-UHFFFAOYSA-N |
CAS Registry1214099-39-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endocrinology and Metabolic Disease | Preclinical | DE | 11 Mar 2021 |